Pretreatment Brain Connectome Fingerprint Predicts Treatment Response in Major Depressive Disorder

BACKGROUND: Major depressive disorder (MDD) treatment is characterized by low remission rate and often involves weeks to months of treatment. Identification of pretreatment biomarkers of response may play a critical role in novel drug development, in enhanced prognostic predictions, and perhaps in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Siyan, Nemati, Samaneh, Akiki, Teddy J., Roscoe, Jeremy, Averill, Christopher L., Fouda, Samar, Averill, Lynnette A., Abdallah, Chadi G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783890/
https://www.ncbi.nlm.nih.gov/pubmed/33458556
http://dx.doi.org/10.1177/2470547020984726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783890/
https://www.ncbi.nlm.nih.gov/pubmed/33458556
http://dx.doi.org/10.1177/2470547020984726

Ejemplares similares